If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.
Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.
Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.
S06-115 Validation of new protein analysis methodology through conditional transgenic mouse models
Stanford researchers have developed the use of a nano-fluidic proteomic immunoassay (NIA) to quantify total and phosphorylated forms of oncoproteins in nanoscale tumor samples. They developed NIA by combining the use of an automated microfluidic instrumen... more information »
S02-291 Treatment of Cancer using Apoptolidin Analogues, Derivatives and Formulations Thereof
Dr. Paul Wender and his colleagues at Stanford have discovered analogues and have prepared derivatives of the natural product apoptolidin that can selectively induce apoptosis (programmed cell death) in cancer cells with a therapeutic window of several or... more information »
What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests
for additional information. TechFinder contains text and images. TechFinder is updated within
minutes of any changes made at Stanford's Office of Technology Licensing.